SLQT

$0.60-0.02 (-3.81%)

Market ClosedAs of Mar 20, 8:00 PM UTC

SelectQuote, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JPMBACGS

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.60
Potential Upside
5%
Whystock Fair Value$0.63
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorFinancial Services
IndustryInsurance Brokers

SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Servi...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$105.09M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.25
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
7.68%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.81

Recent News

Zacks
Mar 18, 2026

Lemonade (LMND) Soars 15.8%: Is Further Upside Left in the Stock?

Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Insider Monkey
Feb 25, 2026

SelectQuote (SLQT) Reports 12% Revenue Growth, Supported Liquidity Through $415M Refinancing

SelectQuote Inc. (NYSE:SLQT) is one of the best penny stocks under $1 to buy right now. On February 5, SelectQuote reported a 12% year-over-year revenue increase to $537 million for FQ2 2026, driven by a strong performance in its senior segment and a 26% revenue jump for SelectRx. To support its expansion, SelectQuote secured a […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 23, 2026

How The SelectQuote (SLQT) Narrative Is Resetting As Fair Value Targets Recalibrate

SelectQuote’s updated analyst narrative now centers on a fair value move from $4.50 to about $3.06 per share, a sizable reset in where some models see the stock’s potential. Bulls view this shift as a cleaner, more execution focused starting point, while bears see it as a sign that earlier expectations were too aggressive. As you read on, you will see how to track these evolving views and what to watch if you are following the story. Stay updated as the Fair Value for SelectQuote shifts by...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Feb 9, 2026

SelectQuote, Inc. (SLQT) Implements Strategic and Financial Initiatives to Support Expansion

SelectQuote, Inc. (NYSE:SLQT) is one of the best NYSE penny stocks to buy now. On January 15, SelectQuote, Inc. (NYSE:SLQT) announced that its SelectRx pharmacy has signed a new multi-year agreement with a major pharmacy benefit manager (PBM), effective January 1, 2026. The agreement paves the way for greater visibility into reimbursement rates while offering […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Feb 7, 2026

SelectQuote Q2 Earnings Call Highlights

SelectQuote (NYSE:SLQT) management highlighted what it described as a “strong quarter” driven by solid execution during the Medicare Advantage annual enrollment period (AEP), continued growth in its Healthcare Services segment, and recently announced financing and pharmacy benefit manager (PBM) agre

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.